VOXELOTOR - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2022-07-20
- Label type
- Indexing - product concept
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-05 00:20:23
Label at a glance#
ProductVOXELOTOR
Active ingredientVOXELOTOR
Products#
Every source-derived product name is available through these pages.
- VOXELOTOR
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| VOXELOTOR | 3ZO554A4Q8 | ACTIB |
| VOXELOTOR | 3ZO554A4Q8 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OXBRYTA | VOXELOTOR | Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc. | 3c557fac-29ec-483f-b691-8a935d4decc3 | 2023-12-26 | Warnings, Adverse reactions | VOXELOTOR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.